Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting glioblastoma through nano- and micro-particle-mediated immune modulation.
Bioorg Med Chem. 2022 Oct 15;72:116913. doi: 10.1016/j.bmc.2022.116913. Epub 2022 Jul 8.
Bioorg Med Chem. 2022.
PMID: 36007293
Free article.
Review.
Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability.
Maguregui A, Abe H.
Maguregui A, et al.
Chembiochem. 2020 Jul 1;21(13):1808-1815. doi: 10.1002/cbic.202000009. Epub 2020 May 18.
Chembiochem. 2020.
PMID: 32181563
Review.
Item in Clipboard
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
Fiorino G, Ruiz-Argüello MB, Maguregui A, Nagore D, Correale C, Radice S, Gilardi D, Allocca M, Furfaro F, Martínez A, Danese S.
Fiorino G, et al. Among authors: maguregui a.
Inflamm Bowel Dis. 2018 Feb 15;24(3):601-606. doi: 10.1093/ibd/izx086.
Inflamm Bowel Dis. 2018.
PMID: 29462398
Item in Clipboard
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars.
Ruiz-Argüello MB, Maguregui A, Ruiz Del Agua A, Pascual-Salcedo D, Martínez-Feito A, Jurado T, Plasencia C, Balsa A, Llinares-Tello F, Rosas J, Torres N, Martínez A, Nagore D.
Ruiz-Argüello MB, et al. Among authors: maguregui a.
Ann Rheum Dis. 2016 Sep;75(9):1693-6. doi: 10.1136/annrheumdis-2015-208684. Epub 2016 Mar 10.
Ann Rheum Dis. 2016.
PMID: 26965981
Item in Clipboard
Cite
Cite